Evogene Ltd.EVGNNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+93.4%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+93.4%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
7.2x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 186.82% |
| Q2 2025 | -72.48% |
| Q1 2025 | -705.85% |
| Q4 2024 | 105.60% |
| Q3 2024 | -40.80% |
| Q2 2024 | -40.28% |
| Q1 2024 | 41.48% |
| Q4 2023 | -65.69% |
| Q3 2023 | 43.27% |
| Q2 2023 | -11.99% |
| Q1 2023 | -109.17% |
| Q4 2022 | 54.19% |
| Q3 2022 | 25.81% |
| Q2 2022 | -6.60% |
| Q1 2022 | -12.26% |
| Q4 2021 | 3.14% |
| Q3 2021 | -22.54% |
| Q2 2021 | 5.94% |
| Q1 2021 | 18.71% |
| Q4 2020 | -69.70% |
| Q3 2020 | -12.93% |
| Q2 2020 | 31.95% |
| Q1 2020 | -2.47% |
| Q4 2019 | -43.65% |
| Q3 2019 | -3.35% |
| Q2 2019 | -10.38% |
| Q1 2019 | 36.06% |
| Q4 2018 | -20.80% |
| Q3 2018 | -0.69% |
| Q2 2018 | 11.46% |
| Q1 2018 | 13.46% |
| Q4 2017 | -23.89% |
| Q3 2017 | -5.92% |
| Q2 2017 | 2.15% |
| Q1 2017 | 27.04% |
| Q4 2016 | -29.90% |
| Q3 2016 | -14.59% |
| Q2 2016 | -32.35% |
| Q1 2016 | 38.38% |
| Q4 2015 | -61.80% |